124 results on '"Schmidt, Erik B."'
Search Results
102. n-3 fatty acids from fish and coronary artery disease: implications for public health
- Author
-
Schmidt, Erik B, primary, Skou, Helle A, additional, Christensen, Jeppe H, additional, and Dyerberg, Jørn, additional
- Published
- 2000
- Full Text
- View/download PDF
103. Adipose tissue trans-fatty acids and changes in body weight and waist circumference.
- Author
-
Hansen, Camilla P., Berentzen, Tina L., Østergaard, Jane N., Dahm, Christina C., Hellgren, Lars I., Schmidt, Erik B., Tjønneland, Anne, Sørensen, Thorkild I. A., Overvad, Kim, and Jakobsen, Marianne U.
- Subjects
ADIPOSE tissues ,BODY weight ,LONGITUDINAL method ,QUESTIONNAIRES ,REGRESSION analysis ,RESEARCH funding ,STATISTICAL sampling ,TRANS fatty acids ,MULTIPLE regression analysis ,BODY mass index ,DATA analysis software ,WAIST circumference - Abstract
Previous studies have suggested that the intake of trans-fatty acids (TFA) plays a role in the development of obesity. The proportions of adipose tissue fatty acids not synthesised endogenously in humans, such as TFA, usually correlate well with the dietary intake. Hence, the use of these biomarkers may provide a more accurate measure of habitual TFA intake than that obtained with dietary questionnaires. The objective of the present study was to investigate the associations between the proportions of specific TFA in adipose tissue and subsequent changes in weight and waist circumference (WC). The relative content of fatty acids in adipose tissue biopsies from a random sample of 996 men and women aged 50–64 years drawn from a Danish cohort study was determined by GC. Baseline data on weight, WC and potential confounders were available together with information on weight and WC 5 years after enrolment. The exposure measures were total trans-octadecenoic acids (18 : 1t), 18 : 1 Δ6-10t, vaccenic acid (18 : 1 Δ11t) and rumenic acid (18 : 2 Δ9c, 11t). Data were analysed using multiple regression with cubic spline modelling. The median proportion of total adipose tissue 18 : 1t was 1·52 % (90 % central range 0·98, 2·19) in men and 1·47 % (1·01, 2·19) in women. No significant associations were observed between the proportions of total 18 : 1t, 18 : 1 Δ6-10t, vaccenic acid or rumenic acid and changes in weight or WC. The present study suggests that the proportions of specific TFA in adipose tissue are not associated with subsequent changes in weight or WC within the exposure range observed in this population. [ABSTRACT FROM PUBLISHER]
- Published
- 2014
- Full Text
- View/download PDF
104. No association between the intake of marine n-3 PUFA during the second trimester of pregnancy and factors associated with cardiometabolic risk in the 20-year-old offspring.
- Author
-
Rytter, Dorte, Bech, Bodil H., Halldorsson, Thorhallur, Christensen, Jeppe H., Schmidt, Erik B., Danielsen, Inge, Henriksen, Tine B., and Olsen, Sjurdur F.
- Subjects
ADIPOSE tissues ,BLOOD pressure ,HUMAN body composition ,C-reactive protein ,CARDIOVASCULAR diseases ,CHI-squared test ,CHOLESTEROL ,CONFIDENCE intervals ,GLYCOSYLATED hemoglobin ,HEART beat ,HIGH density lipoproteins ,INSULIN resistance ,INTERVIEWING ,LONGITUDINAL method ,LOW density lipoproteins ,RESEARCH methodology ,OMEGA-3 fatty acids ,QUESTIONNAIRES ,RESEARCH funding ,SEAFOOD ,STATISTICAL hypothesis testing ,T-test (Statistics) ,TRIGLYCERIDES ,LEPTIN ,MULTIPLE regression analysis ,DATA analysis software ,ADIPONECTIN ,WAIST circumference ,PRENATAL exposure delayed effects ,ADULTS ,PREGNANCY - Abstract
The intake of marine n-3 PUFA has been shown to decrease the risk of CVD in a number of studies. Since the development of CVD is often a lifelong process, marine n-3 PUFA intake early in life may also affect the development of later CVD. The aim of the present study was to investigate the association between maternal intake of marine n-3 PUFA during the second trimester of pregnancy and factors associated with cardiometabolic risk in the 20-year-old offspring. The study was based on the follow-up of the offspring of a Danish pregnancy cohort who participated in a study conducted from 1988 to 1989. A total of 965 pregnant women were originally included in the cohort and detailed information about the intake of marine n-3 PUFA during the second trimester was collected. In 2008–9, the offspring were invited to participate in a clinical examination including anthropometric, blood pressure (BP) and short-term heart rate variability measurements. Also, a fasting venous blood sample was drawn from them. Multiple linear regression modelling, using the lowest quintile of marine n-3 PUFA intake as the reference, was used to estimate the association with all outcomes. A total of 443 offspring participated in the clinical examination. No association between the intake of marine n-3 PUFA during the second trimester of pregnancy and offspring adiposity, glucose metabolism, BP or lipid profile was found. In conclusion, no association between the intake of marine n-3 PUFA during the second trimester of pregnancy and the factors associated with cardiometabolic risk in the 20-year-old offspring could be detected. [ABSTRACT FROM PUBLISHER]
- Published
- 2013
- Full Text
- View/download PDF
105. n-3 fatty acids and ventricular extrasystoles in patients with ventricular tachyarrhythmias
- Author
-
Christensen, Jeppe H., primary, Gustenhoff, Peter, additional, Ejlersen, Ejler, additional, Jessen, Torben, additional, Korup, Eva, additional, Rasmussen, Klaus, additional, Dyerberg, Jørn, additional, and Schmidt, Erik B., additional
- Published
- 1995
- Full Text
- View/download PDF
106. PPARγ Pro12Ala polymorphism and risk of acute coronary syndrome in a prospective study of Danes.
- Author
-
Vogel, Ulla, Segel, Stine, Dethlefsen, Claus, Tjønneland, Anne, Saber, Anne Thoustrup, Wallin, Håkan, Jensen, Majken K., Schmidt, Erik B., Andersen, Paal Skytt, and Overvad, Kim
- Subjects
CORONARY disease ,SYNDROMES ,PEROXISOMES ,FAT cells ,LIPIDS - Abstract
Background: Acute coronary syndrome (ACS) is a major cause of morbidity and mortality in the western world. Peroxisome proliferator-activated receptor γ (PPARγ) plays a key role in the regulation of the energy balance, adipocyte differentiation and lipid biosynthesis. The aim was to investigate if the polymorphism PPAR γ2 Pro
12 Ala, which encodes a less efficient transcription factor, was associated with risk of acute coronary disease and if there were interactions between this polymorphism and factors that modify PPARγ activity, such as alcohol intake, smoking, and use of non-steroidal anti-inflammatory medicine. Methods: A case-cohort study including 1031 ACS cases and a sub-cohort of 1703 persons was nested within the population-based prospective study Diet, Cancer and Health of 57,053 individuals. Results: Homozygous male variant allele carriers of PPAR γ2 Pro12 Ala were at higher risk of ACS (HR = 2.12, 95% CI: 1.00-4.48) than homozygous carriers of the Pro-allele. Among men, there was a statistically significant interaction between genotypes and alcohol intake such that homozygous variant allele carriers with a low alcohol intake were at higher risk of ACS (HR = 25.3, CI: 16.5-38.7) compared to homozygous common allele carriers (p for interaction < 0.0001). Overall, the association was only observed among homozygous variant allele carriers. Thus, all the observed associations were obtained in subgroups including small numbers of cases. It is therefore possible that the observed associations were due to chance. Conclusion: In the present study, there were no consistent associations between PPARγ Pro12 Ala and risk of ACS, and no consistent interaction with alcohol, BMI, NSAID or smoking in relation to ACS. [ABSTRACT FROM AUTHOR]- Published
- 2009
- Full Text
- View/download PDF
107. The effect of dietary n-3 fatty acids on serum concentrations of C-reactive protein: a dose???response study.
- Author
-
Madsen, Trine, Christensen, Jeppe H., Blom, Mogens, and Schmidt, Erik B.
- Abstract
C-reactive protein (CRP) is a sensitive marker for low-grade inflammation. Long-chain n-3 polyunsaturated fatty acids (PUFA) have anti-inflammatory effects. The objective of the present study was to investigate the effect on serum levels of CRP of n-3 PUFA at two different doses. We also investigated correlations between CRP and the cellular contents of PUFA. Sixty healthy volunteers (twenty-five women and thirty-five men) were randomly assigned to three treatment groups in a double-blind design. The subjects received a supplement of either 6??6 g n-3 PUFA/d, 2??0 g n-3 PUFA/d or placebo (olive oil) for 12 weeks. CRP was measured using a highly sensitive assay. The median serum CRP concentration was 0??78 mg/l. No significant correlations were found between CRP and the content of n-3 PUFA in granulocytes or platelets. Subjects receiving n-3 PUFA had a significant (P<0??01) increase in the cellular contents of 20: 5n-3, 22: 5n-3 and 22: 6n-3, with the largest increase occurring in the group receiving 6??6 g PUFA/d. A significant (P<0??01) decrease in cellular content of 18: 2n-6 and 20: 4n-6 was observed simultaneously. Serum CRP concentrations, however, were unaffected by the PUFA-containing supplements. The present study shows that dietary supplementation with PUFA-containing supplements has no effect on serum concentrations of CRP, measured with a highly sensitive assay, in healthy subjects. [ABSTRACT FROM PUBLISHER]
- Published
- 2003
- Full Text
- View/download PDF
108. Substitution of Fish for Red Meat or Poultry and Risk of Ischemic Stroke.
- Author
-
Venø, Stine K., Bork, Christian S., Jakobsen, Marianne U., Lundbye-Christensen, Søren, Bach, Flemming W., McLennan, Peter L., Tjønneland, Anne, Schmidt, Erik B., and Overvad, Kim
- Abstract
We investigated the risk of ischemic stroke and its subtypes when red meat or poultry was substituted with fish. A total of 57,053 participants aged 50–65 years at baseline were included in the Danish Diet, Cancer and Health study. All participants filled in a food-frequency questionnaire at recruitment. Potential ischemic stroke cases were identified by linkage to the Danish National Patient Register, and all cases were validated and subclassified. Substitutions were investigated as 150 g/week of fish for 150 g/week of red meat or of poultry using multivariable Cox proportional hazard regression models. During 13.5 years of follow-up, 1879 participants developed an ischemic stroke. Replacing red meat or poultry with fish was not associated with the rate of total ischemic stroke, but there was a statistically significant lower rate of large artery atherosclerosis when fish replaced processed (hazard ratio (HR): 0.78; 95% confidence interval (CI): 0.67; 0.90) and unprocessed (HR: 0.87; 95% CI: 0.75; 0.99) red meat. A statistically significant higher rate of cardioembolism was found when poultry was replaced by total fish (HR: 1.42; 95% CI: 1.04; 1.93). When fatty fish replaced unprocessed red meat, a statistically significant lower rate of small-vessel occlusion was found (HR: 0.88; 95% CI: 0.77; 0.99). In conclusion, replacing red meat with fish was not associated with risk of total ischemic stroke but was associated with a lower risk of subtypes of ischemic stroke. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
109. Fatty Acid Composition in Various Types of Cardiac Adipose Tissues and Its Relation to the Fatty Acid Content of Atrial Tissue.
- Author
-
Hjelmgaard, Katrin, Eschen, Rikke B., Schmidt, Erik B., Andreasen, Jan J., and Lundbye-Christensen, Søren
- Abstract
Diet, with its content of various types of fatty acids (FAs), is of great importance for cellular function. Adipose tissue (AT) serves as a storage for dietary FAs, but after appropriate activation it may also offer important biological properties, e.g., by releasing adipokines and cytokines to the surrounding milieu. Such effects may depend on the diet and type of FA involved. Similarly, the composition of FAs in the heart is also likely to be important for cardiac function. We investigated samples of epicardial adipose tissue (EAT), pericardial adipose tissue (PAT), subcutaneous adipose tissue (SCAT), and tissue from the right atrial appendage to compare the FA compositions in patients undergoing elective cardiac surgery. Minor differences among AT compartments were found, while the comparison of atrial tissue and EAT showed major differences in saturated fatty acids (SFAs), monounsaturated fatty acids (MUFAs), and n-3 and n-6 polyunsaturated fatty acids (PUFAs). These findings may be of importance for understanding biological availability, dietary effects, and the effects of FAs on the heart. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
110. Haemostatic Aspects of Renal Transplantation
- Author
-
Sørensen, Per J., primary, Schmidt, Erik B., additional, Knudsen, Flemming, additional, Nielsen, Arne H., additional, Kristensen, Sten D., additional, Dyerberg, Jørn, additional, and Kornerup, Hans J., additional
- Published
- 1988
- Full Text
- View/download PDF
111. Perforated Peptic Ulcer—a Complication in Acute Salicylate Intoxication
- Author
-
CHRISTENSEN, LISBET A., primary and SCHMIDT, ERIK B., additional
- Published
- 1987
- Full Text
- View/download PDF
112. Effects of Marine n-3 Polyunsaturated Fatty Acids on Heart Rate Variability and Heart Rate in Patients on Chronic Dialysis: A Randomized Controlled Trial.
- Author
-
Rantanen, Jesper M., Christensen, Jeppe H., Riahi, Sam, Schmidt, Erik B., and Johansen, Martin B.
- Abstract
Marine n-3 polyunsaturated fatty acids (PUFA) may improve autonomic dysfunction, as indicated by an increase in heart rate variability (HRV) and reduce the risk of sudden cardiac death. Hence, the aim of this study was to investigate the effects of marine n-3 PUFA on 24-h HRV in patients on chronic dialysis, who have a high risk of sudden cardiac death. Between June 2014 and March 2016, 112 patients on chronic dialysis from Denmark were allocated to a daily supplement of 2 g marine n-3 PUFA or control for three months in a randomized, double-blinded, controlled trial. A 48-h Holter monitoring was performed and mean 24-h HRV indices for the two days were available in 85 patients. The mean age was 62.3 years (SD: 14.3) and median dialysis vintage was 1.7 years (IQR: 0.5, 6.4). Within-group and between-group changes in outcome were evaluated by a paired and two sample t-test, respectively. Marine n-3 PUFA did not change the primary endpoint SDNN (SD of all RR-intervals) reflecting overall HRV, but other HRV indices increased and the mean RR-interval increased significantly, corresponding to a decrease in heart rate by 2.5 beats per minute (p = 0.04). In conclusion, marine n-3 PUFA did not change SDNN, but the mean heart rate was significantly reduced and changes in other HRV-indices were also observed, indicating an increase in vagal modulation that might be protective against malignant ventricular arrhythmias. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
113. Intake of marine and plant-derived n-3 fatty acids and development of atherosclerotic cardiovascular disease in the Danish Diet, Cancer and Health cohort.
- Author
-
Bork, Christian S., Lundbye-Christensen, Søren, Venø, Stine K., Lasota, Anne N., Tjønneland, Anne, Schmidt, Erik B., and Overvad, Kim
- Subjects
- *
ATHEROSCLEROSIS risk factors , *ISCHEMIA , *RISK assessment , *OMEGA-3 fatty acids , *RESEARCH funding , *DESCRIPTIVE statistics , *SEAFOOD , *LONGITUDINAL method , *PROPORTIONAL hazards models , *DISEASE risk factors - Abstract
Purpose: The objective of this study was to investigate the association between intake of seafood and plant-derived n-3 polyunsaturated fatty acids (PUFA) and development of total atherosclerotic cardiovascular disease (ASCVD) and acute major ischemic events. Methods: A total of 53,909 men and women were enrolled between 1993 and 1997 into the Danish Diet, Cancer and Health cohort and followed through nationwide Danish registries for development of total ASCVD defined as a first registration of myocardial infarction, peripheral artery disease, or ischemic stroke due to large artery atherosclerosis or small-vessel occlusion. At recruitment, the intake of the major marine n-3 PUFA, eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) and the plant-derived n-3 PUFA, alpha-linolenic acid (ALA), was assessed using a validated food frequency questionnaire. Statistical analyses were conducted using sex-stratified multivariable Cox proportional hazard regression models. Results: During a median of 13.5 years of follow-up, 3958 participants developed ASCVD including 3270 patients with an acute major ischemic event. In multivariable analyses including adjustment for established risk factors, we found no associations for intake of ALA, but indications of inverse associations between intake of EPA, DHA and EPA + DHA and the rate of total ASCVD and acute major ischemic events. Conclusions: A high intake of marine n-3 PUFA was associated with a lower risk of total ASCVD and acute major ischemic events, whereas no association could be demonstrated for the plant-derived ALA. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
114. Plant n-3 PUFA intake may lower the risk of atherosclerotic cardiovascular disease only among subjects with a low intake of marine n-3 PUFAs.
- Author
-
Bork, Christian S., Lundbye-Christensen, Søren, Venø, Stine K., Lasota, Anne N., Schmidt, Erik B., and Overvad, Kim
- Subjects
- *
ATHEROSCLEROSIS prevention , *UNSATURATED fatty acids , *ALPHA-linolenic acid , *CARDIOVASCULAR diseases risk factors , *RISK assessment , *PLANT extracts - Abstract
The role of the major plant-derived n-3 PUFA, alpha-linolenic acid (ALA), on the risk of atherosclerotic cardiovascular (ASCVD) remains unclear, but most studies have reported no association. However, the association between intake of ALA and the risk of ASCVD may depend on the intake of marine n-3 PUFAs. We investigated this hypothesis among more than 53,909 middle-aged, Danish men and women followed for a median of 13.4 years. We found a statistically significant inverse association between ALA intake modelled as a restricted cubic spline and the rate of ASCVD in subjects with a low intake of marine n-3 PUFAs, while no association was observed among subjects with a higher intake of marine n-3 PUFAs. Our findings suggest that the intake of ALA may be associated with a lower risk of total ASCVD, but only among subjects with a low intake of marine n-3 PUFAs. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
115. Adipose tissue content of alpha-linolenic acid and development of peripheral artery disease: a Danish case-cohort study.
- Author
-
Bork, Christian S., Lasota, Anne N., Lundbye-Christensen, Søren, Jakobsen, Marianne U., Tjønneland, Anne, Overvad, Kim, and Schmidt, Erik B.
- Subjects
- *
ADIPOSE tissues , *BIOMARKERS , *DIET , *GAS chromatography , *HEALTH status indicators , *LONGITUDINAL method , *MULTIVARIATE analysis , *PERIPHERAL vascular diseases , *TUMORS , *PROPORTIONAL hazards models , *CASE-control method , *DESCRIPTIVE statistics , *ALPHA-linolenic acid - Abstract
Purpose: The aim of this study was to investigate the association between adipose tissue content of the plant-derived n-3 fatty acid, alpha-linolenic acid, and the rate of incident peripheral artery disease (PAD). Methods: We conducted a case-cohort study nested within the Danish Diet, Cancer and Health cohort (n = 57,053), which was established between 1993 and 1997. Potential PAD cases were identified using linkage with The Danish National Patient Register and all potential cases were validated. Adipose tissue samples from the buttock were collected at baseline and fatty acid composition was determined in cases and in a random sample (n = 3500) from the cohort by gas chromatography. Statistical analyses were performed using weighted Cox regression allowing for different baseline hazards among sexes. Results: During a median of 13.5 years of follow-up, we identified 863 PAD cases with complete information. The median adipose tissue content of ALA in the sub-cohort (n = 3197) was 0.84% (interquartile range 0.73–0.94%) of total fatty acids. In multivariate analyses including adjustment for established risk factors, we observed a U-shaped association between ALA in adipose tissue and rate of PAD, but the association was not statistically significant (P = 0.131). Similar pattern of associations were observed between ALA content in adipose tissue and the rate of PAD among men and women. Conclusions: We found indications of a U-shaped association between adipose tissue content of ALA and the rate of PAD, but the association was not statistically significant. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
116. Temporal trends in mortality in patients with rheumatoid arthritis: a Danish population-based matched cohort study.
- Author
-
Soussi BG, Duch K, Cordtz RL, Lindhardsen J, Kristensen S, Bork CS, Linauskas A, Schmidt EB, and Dreyer L
- Subjects
- Male, Humans, Female, Middle Aged, Cohort Studies, Incidence, Registries, Denmark epidemiology, Arthritis, Rheumatoid epidemiology
- Abstract
Objectives: To investigate the 5-year all-cause mortality in patients with RA compared with the general population., Methods: This was a nationwide population-based matched cohort study. RA patients diagnosed between 1996 and the end of 2015 were identified using administrative heath registries and followed until the end of 2020 allowing 5 years of follow-up. Patients with incident RA were matched 1:5 on year of birth and sex with non-RA individuals from the Danish general population. Time-to-event analyses were performed using the pseudo-observation approach., Results: Compared with matched controls in 1996-2000, the risk difference for RA patients ranged from 3.5% (95% CI 2.7%, 4.4%) in 1996-2000 to -1.6% (95% CI -2.3%, -1.0%) in 2011-15, and the relative risk from 1.3 (95% CI 1.2, 1.4) in 1996-2000 to 0.9 (95% CI 0.8, 0.9) in 2011-15. The age-adjusted 5-year cumulative incidence proportion of death for a 60-year-old RA patient decreased from 8.1% (95% CI 7.3%, 8.9%) when diagnosed in 1996-2000 to 2.9% (95% CI 2.3%, 3.5%) in 2011-15, and for matched controls from 4.6% (95% CI 4.2%, 4.9%) to 2.1% (95% CI 1.9%, 2.4%). Excess mortality persisted in women with RA throughout the study period, while the mortality risk for men with RA in 2011-15 was similar to their matched controls., Conclusions: Enhanced improvement in mortality was found in RA patients compared with matched controls, but for sex-specific differences excess mortality was only persistent in women with RA., (© The Author(s) 2023. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For permissions, please email: journals.permissions@oup.com.)
- Published
- 2024
- Full Text
- View/download PDF
117. Omega-3 Fatty Acid Biomarkers and Incident Atrial Fibrillation.
- Author
-
Qian F, Tintle N, Jensen PN, Lemaitre RN, Imamura F, Feldreich TR, Nomura SO, Guan W, Laguzzi F, Kim E, Virtanen JK, Steur M, Bork CS, Hirakawa Y, O'Donoghue ML, Sala-Vila A, Ardisson Korat AV, Sun Q, Rimm EB, Psaty BM, Heckbert SR, Forouhi NG, Wareham NJ, Marklund M, Risérus U, Lind L, Ärnlöv J, Garg P, Tsai MY, Pankow J, Misialek JR, Gigante B, Leander K, Pester JA, Albert CM, Kavousi M, Ikram A, Voortman T, Schmidt EB, Ninomiya T, Morrow DA, Bayés-Genís A, O'Keefe JH, Ong KL, Wu JHY, Mozaffarian D, Harris WS, and Siscovick DS
- Subjects
- Humans, Biomarkers, Docosahexaenoic Acids, Eicosapentaenoic Acid, Prospective Studies, Risk Factors, Atrial Fibrillation diagnosis, Atrial Fibrillation epidemiology, Fatty Acids, Omega-3
- Abstract
Background: The relationship between omega-3 fatty acids and atrial fibrillation (AF) remains controversial., Objectives: This study aimed to determine the prospective associations of blood or adipose tissue levels of eicosapentaenoic acid (EPA), docosapentaenoic acid (DPA), and docosahexaenoic acid (DHA) with incident AF., Methods: We used participant-level data from a global consortium of 17 prospective cohort studies, each with baseline data on blood or adipose tissue omega-3 fatty acid levels and AF outcomes. Each participating study conducted a de novo analyses using a prespecified analytical plan with harmonized definitions for exposures, outcome, covariates, and subgroups. Associations were pooled using inverse-variance weighted meta-analysis., Results: Among 54,799 participants from 17 cohorts, 7,720 incident cases of AF were ascertained after a median 13.3 years of follow-up. In multivariable analysis, EPA levels were not associated with incident AF, HR per interquintile range (ie, the difference between the 90th and 10th percentiles) was 1.00 (95% CI: 0.95-1.05). HRs for higher levels of DPA, DHA, and EPA+DHA, were 0.89 (95% CI: 0.83-0.95), 0.90 (95% CI: 0.85-0.96), and 0.93 (95% CI: 0.87-0.99), respectively., Conclusions: In vivo levels of omega-3 fatty acids including EPA, DPA, DHA, and EPA+DHA were not associated with increased risk of incident AF. Our data suggest the safety of habitual dietary intakes of omega-3 fatty acids with respect to AF risk. Coupled with the known benefits of these fatty acids in the prevention of adverse coronary events, our study suggests that current dietary guidelines recommending fish/omega-3 fatty acid consumption can be maintained., Competing Interests: Funding Support and Author Disclosures The Fatty Acid Research Institute retrospectively provided a small honorarium to a subset of the analysts who participated in this study, but it had no role in the design, analysis, manuscript writing, nor decision to submit for publication. Detailed funding information for the individual cohorts can be found in the Supplemental Appendix, specifically Supplemental Table 4. None of the funders/sponsors played any role in the collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; or decision to submit the manuscript for publication. Dr O'Donoghue is a member of the TIMI Study Group, which has received institutional research grant support through Brigham and Women’s Hospital from Amgen, Novartis, Janssen, and AstraZeneca; and has received consulting fees from Amgen, Novartis, Janssen, and AstraZeneca. Dr Albert has received consulting fees from Boston Scientific, Medtronic, Novartis, and Element Science. Dr Morrow is a member of the TIMI Study group, which has received institutional research grant support through Brigham and Women’s Hospital from Abbott Laboratories, Amgen, Anthos Therapeutics, Arca Biopharma, AstraZeneca, Bayer HealthCare Pharmaceuticals, Inc, Daiichi-Sankyo, Eisai, Intarcia, Janssen, Merck, Novartis, Pfizer, Quark Pharmaceuticals, Regeneron, Roche, Siemens, The Medicines Company, and Zora Biosciences; and has received consulting fees from ARCA, InCarda, Inflammatix, Merck, Novartis, and Roche Diagnostics. Dr O’Keefe has a major ownership interest in Cardiotabs (a company that markets supplements including omega-3). Dr Mozaffarian, outside of the submitted work, has received research funding from the Gates Foundation, The Rockefeller Foundation, and the Vail Institute for Global Research; has received personal fees from Acasti Pharma, Barilla, Danone, and Motif FoodWorks; has served on the scientific advisory board of Beren Therapeutics, Brightseed, Calibrate, DayTwo (ended June 20, 2023), Elysium Health, Filtricine, Foodome, HumanCo, January Inc, Perfect Day, Season, and Tiny Organics; has stock ownership in Calibrate and HumanCo; and has chapter royalties from UpToDate. Dr Harris holds stock in OmegaQuant Analytics, LLC (a laboratory that offers blood fatty acid testing); and is on the Scientific Advisory Boards for the Schiff Institute Science and Innovation, Synspira, and the Seafood Nutrition Partnership. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose., (Copyright © 2023 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
118. Do omega-3 fatty acids increase risk of atrial fibrillation?
- Author
-
Bork CS, Myhre PL, and Schmidt EB
- Subjects
- Humans, Dietary Supplements, Follow-Up Studies, Observational Studies as Topic, Risk, Atrial Fibrillation etiology, Atrial Fibrillation prevention & control, Fatty Acids, Omega-3
- Abstract
Purpose of the Review: To summarize the findings from recent observational follow-up studies and randomized trials of plant- and marine omega-3 fatty acids on the risk of atrial fibrillation (AF)., Recent Findings: Recent randomized cardiovascular outcome trials have indicated that supplements with marine omega-3 fatty acids may be associated with a higher risk of AF, and a meta-analysis has suggested that marine omega-3 fatty acid supplements were associated with a 25% higher relative risk of AF. Also, a recent large observational study reported a modest higher risk of AF in habitual users of marine omega-3 fatty acid supplements. However, recent observational biomarker studies of circulating and adipose tissue content of marine omega-3 fatty acids have in contrast reported a lower risk of AF. Very limited knowledge exists on the role of plant-derived omega-3 fatty acids and AF., Summary: Marine omega-3 fatty acid supplements may increase the risk of AF, whereas biomarkers reflecting consumption of marine omega-3 fatty acids have been linked to a lower risk of AF. Clinicians should inform patients that marine omega-3 fatty acid supplement may increase AF risk, and this should be taking into account when discussing pros and cons of taking supplements with marine omega-3 fatty acids., (Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
119. Intake of marine n-3 polyunsaturated fatty acids and the risk of incident peripheral artery disease.
- Author
-
Tram L, Bork CS, Venø SK, Lasota AN, Lundbye-Christensen S, Schmidt EB, and Overvad K
- Subjects
- Cohort Studies, Docosahexaenoic Acids, Eicosapentaenoic Acid, Fatty Acids, Unsaturated, Humans, Fatty Acids, Omega-3, Peripheral Arterial Disease epidemiology, Peripheral Arterial Disease etiology, Peripheral Arterial Disease prevention & control
- Abstract
Background: A high intake of marine n-3 polyunsaturated fatty acids (PUFAs) may lower the risk of coronary heart disease and ischemic stroke. The association between intake of marine n-3 PUFAs and development of peripheral artery disease (PAD), however, remains unexplored. We hypothesised that intake of marine n-3 PUFAs, eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA) and the sum of EPA + DHA was associated with a lower risk of incident PAD., Methods: We used data from the Danish Diet, Cancer and Health cohort and investigated the associations between intake of EPA, DHA and EPA + DHA and development of PAD. Information on intake of n-3 PUFAs was obtained through a validated food frequency questionnaire. Potential PAD cases were identified through linkage to the Danish National Patient Register and subsequently, all cases were validated., Results: Data were available from 55,248 participants and during a median of 13.6 years of follow-up, 950 cases of PAD were identified. Multivariate Cox regression analyses with adjustments for established risk factors showed no statistically significant associations between intake of EPA (p = 0.255), DHA (p = 0.071) or EPA + DHA (p = 0.168) and the rate of incident PAD., Conclusions: We did not confirm our hypothesis that intake of EPA, DHA or EPA + DHA was associated with a lower risk of incident PAD., (© 2021. The Author(s), under exclusive licence to Springer Nature Limited part of Springer Nature.)
- Published
- 2021
- Full Text
- View/download PDF
120. Marine and plant-based n -3 PUFA and atherosclerotic cardiovascular disease.
- Author
-
Bork CS, Venø SK, Lasota AN, Lundbye-Christensen S, and Schmidt EB
- Subjects
- Diet, Female, Humans, Male, Risk Factors, Atherosclerosis, Fatty Acids, Omega-3, Fish Oils, Plant Oils
- Abstract
n-3 PUFA may exert favourable effects on several processes that may inhibit the atherosclerotic process. However, the role of n-3 PUFA in lowering the risk of atherosclerotic CVD (ASCVD) has been fiercely debated. In the present paper, we summarise the main findings from previous follow-up studies of intake and studies using adipose tissue as an objective biomarker to investigate exposure to n-3 PUFA in relation to ASCVD risk and discuss some perspectives for further research. The majority of previous studies investigating intake of marine- and plant-based n-3 PUFA have focused on CHD while other ASCVD such as ischaemic stroke and peripheral artery disease have been less studied. However, recent data from Danish Diet, Cancer and Health cohort suggest that marine n-3 PUFA may be inversely associated with risk of myocardial infarction, ischaemic stroke and peripheral arterial disease caused by atherosclerosis. The effect of the plant-derived n-3 PUFA α-linolenic acid on ASCVD is less clear and several gaps in the literature remain to be explored.
- Published
- 2020
- Full Text
- View/download PDF
121. Effects of perioperative supplementation with omega-3 fatty acids on leukotriene B₄ and leukotriene B₅ production by stimulated neutrophils in patients with colorectal cancer: a randomized, placebo-controlled intervention trial.
- Author
-
Sorensen LS, Thorlacius-Ussing O, Rasmussen HH, Lundbye-Christensen S, Calder PC, Lindorff-Larsen K, and Schmidt EB
- Subjects
- Adult, Aged, Aged, 80 and over, Colorectal Neoplasms blood, Colorectal Neoplasms surgery, Double-Blind Method, Eicosapentaenoic Acid administration & dosage, Eicosapentaenoic Acid blood, Eicosapentaenoic Acid pharmacology, Elective Surgical Procedures, Fatty Acids, Omega-3 administration & dosage, Fatty Acids, Omega-3 chemistry, Fatty Acids, Unsaturated administration & dosage, Fatty Acids, Unsaturated pharmacology, Female, Humans, Male, Middle Aged, Neutrophils drug effects, Postoperative Complications diet therapy, Postoperative Complications epidemiology, Postoperative Period, Preoperative Period, Prospective Studies, Treatment Outcome, Colorectal Neoplasms diet therapy, Dietary Supplements, Eicosapentaenoic Acid analogs & derivatives, Fatty Acids, Omega-3 pharmacology, Leukotriene B4 analogs & derivatives, Leukotriene B4 blood
- Abstract
Omega-3 fatty acids (n-3 FA) may have beneficial clinical and immune-modulating effects in surgical patients. In a randomized, double-blind, prospective, placebo-controlled trial, 148 patients referred for elective colorectal cancer surgery received an n-3 FA-enriched oral nutritional supplement (ONS) providing 2.0 g of eicosapentaenoic acid (EPA) and 1.0 g of docosahexaenoic acid (DHA) per day or a standard ONS for seven days before surgery. On the day of operation, there was a significant increase in the production of leukotriene B5 (LTB5) (p < 0.01) and 5-hydroxyeicosapentaenoic acid (5-HEPE) (p < 0.01), a significant decrease in the production of leukotriene B4 (LTB4) (p < 0.01) and a trend for a decrease in the production of 5-hydroxyeicosatetraenoic acid (5-HETE) (p < 0.1) from stimulated neutrophils in the active group compared with controls. There was no association between LTB4 values and postoperative complications. In conclusion, oral n-3 FA exerts anti-inflammatory effects in surgical patients, without reducing the risk of postoperative complications.
- Published
- 2014
- Full Text
- View/download PDF
122. Effect of intravenous omega-3 fatty acid infusion and hemodialysis on fatty acid composition of free fatty acids and phospholipids in patients with end-stage renal disease.
- Author
-
Madsen T, Christensen JH, Toft E, Aardestrup I, Lundbye-Christensen S, and Schmidt EB
- Subjects
- Aged, Double-Blind Method, Female, Fish Oils, Humans, Infusions, Intravenous, Male, Middle Aged, Self Report, Fatty Acids, Nonesterified blood, Fatty Acids, Omega-3 administration & dosage, Kidney Failure, Chronic therapy, Phospholipids blood, Renal Dialysis
- Abstract
Background: Patients treated with hemodialysis (HD) have been reported to have decreased levels of ω-3 polyunsaturated fatty acids (PUFAs) in plasma and cells. The aim of this study was to investigate the effect of ω-3 PUFAs administered intravenously during HD, as well as the effect of HD treatment, on the fatty acid composition of plasma free fatty acids (FFAs), plasma phospholipids, and platelet phospholipids., Methods: Forty-four HD patients were randomized to groups receiving either a single dose of a lipid emulsion containing 4.1 g of ω-3 PUFAs or placebo (saline) administered intravenously during HD. Blood was drawn immediately before (baseline) and after (4 hours) HD and before the next HD session (48 hours). Fatty acid composition was measured using gas chromatography., Results: The increase in ω-3 FFAs was greater in the ω-3 PUFA group compared with the placebo group, whereas the increase in total FFAs was similar between the 2 groups. In the ω-3 PUFA group, ω-3 PUFAs in plasma phospholipids were higher after 48 hours than at baseline, and in platelet phospholipids, ω-3 PUFAs increased after 4 hours. In the placebo group, no changes were observed in ω-3 PUFAs in plasma and platelet phospholipids., Conclusions: Intravenous ω-3 PUFAs administered during HD caused a transient selective increase in ω-3 FFA concentration. Furthermore, ω-3 PUFAs were rapidly incorporated into platelets, and the content of ω-3 PUFAs in plasma phospholipids increased after 48 hours.
- Published
- 2011
- Full Text
- View/download PDF
123. The incorporation of marine n-3 PUFA into platelets and adipose tissue in pre- and postmenopausal women: a randomised, double-blind, placebo-controlled trial.
- Author
-
Witt PM, Christensen JH, Ewertz M, Aardestrup IV, and Schmidt EB
- Subjects
- Adult, Dietary Supplements, Double-Blind Method, Estradiol blood, Estrone blood, Female, Fish Oils, Humans, Middle Aged, Adipose Tissue metabolism, Blood Platelets metabolism, Dietary Fats metabolism, Estrogens blood, Fatty Acids, Omega-3 metabolism, Postmenopause metabolism, Premenopause metabolism
- Abstract
The primary aim of the trial was to investigate the influence of menopause on the incorporation of marine n-3 PUFA into platelets and adipose tissue. A secondary aim was to evaluate whether marine n-3 PUFA may change levels of circulating oestrogens in women. Ninety-two pre- and postmenopausal women were randomly assigned to consume 2.2 g of marine n-3 PUFA or control oil daily for 12 weeks. Adipose tissue biopsies and blood samples were collected at baseline and after intervention. Eighty-nine women completed the study. Baseline contents of total marine n-3 PUFA and each of the major long-chained n-3 PUFA, EPA, docosapentaenoic acid and DHA were all significantly lower (P < 0.05) in the premenopausal group both in platelets and adipose tissue, except for EPA in platelets (P = 0.05). After supplementation with fish oil, the content of all marine n-3 PUFA increased significantly in platelets and adipose tissue in both pre- and postmenopausal women. The increase in platelets and adipose tissue was, however, the same in both groups. There was no effect of fish oil on oestrogen levels in postmenopausal women. We found a significant difference in premenopausal women, in whom oestradiol (P < 0.04) and oestrone (P < 0.02) serum concentrations increased after the fish oil supplement. This trial did not reveal any difference in the ability of pre- and postmenopausal women to incorporate marine n-3 PUFA into platelets or adipose tissue. However, supplementation with fish oil increased oestrogen levels in premenopausal women.
- Published
- 2010
- Full Text
- View/download PDF
124. Dietary intake of total marine n-3 polyunsaturated fatty acids, eicosapentaenoic acid, docosahexaenoic acid and docosapentaenoic acid and the risk of acute coronary syndrome - a cohort study.
- Author
-
Joensen AM, Schmidt EB, Dethlefsen C, Johnsen SP, Tjønneland A, Rasmussen LH, and Overvad K
- Subjects
- Acute Coronary Syndrome epidemiology, Cohort Studies, Denmark, Diet Surveys, Docosahexaenoic Acids administration & dosage, Eicosapentaenoic Acid administration & dosage, Fatty Acids, Unsaturated administration & dosage, Female, Humans, Male, Middle Aged, Proportional Hazards Models, Reference Values, Risk Factors, Sex Factors, Acute Coronary Syndrome prevention & control, Dietary Fats administration & dosage, Fatty Acids, Omega-3 administration & dosage, Seafood
- Abstract
Dietary intake of marine n-3 PUFA has been negatively associated with the risk of CHD among subjects with known CHD, whereas an effect in healthy subjects is less documented. We assessed the hypothesis that dietary intake of marine n-3 PUFA is negatively associated with the risk of acute coronary syndrome (ACS) in healthy subjects. In the Danish Diet, Cancer and Health cohort study, 57 053 participants were enrolled. Dietary intake of total n-3 PUFA, including EPA, docosapentaenoic acid (DPA) and DHA, was assessed. During a mean follow-up period of 7.6 years, we identified all cases (n 1150) from this cohort with an incident ACS diagnosis in the Danish National Patient Registry or the Cause of Death Registry. Diagnoses were verified through medical record review. In Cox proportional hazard models, we adjusted for established risk factors for CHD. Men in the four highest quintiles of n-3 PUFA intake (>0.39 g n-3 PUFA per d) had a lower incidence of ACS compared with men in the lowest quintile. The hazard ratio was 0.83 (95 % CI 0.67, 1.03) when we compared men in the second lowest and lowest quintile of n-3 PUFA intake. Higher intake of n-3 PUFA did not strengthen this association. Associations for EPA, DPA and DHA were all negative, but less consistent. No convincing associations were found among women. In conclusion, we found borderline significant negative associations between the intake of marine n-3 PUFA and ACS among healthy men.
- Published
- 2010
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.